Medications/Drugs News Headlines

(Reuters) - A federal appeals court on Thursday refused to revive Teva Pharmaceutical Industries Ltd's patent infringement suit against AstraZeneca Pharmaceuticals LP for the rights to Crestor, a multibillion-dollar cholesterol fighter. In a ruling that upheld a lower court, the U.S. Court of Appeals for the Federal Circuit …

FRIDAY, Dec. 2 (HealthDay News) -- Topical treatment with moisturizers and emollients such as petroleum jelly should be the first line of therapy for treating psoriasis in pregnant and breast-feeding women, according to new recommendations from the National Psoriasis Foundation Medical Board based in Portland, Ore.

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

NEW YORK (Reuters) - Bristol-Myers Squibb Co and Johnson & Johnson plan to jointly develop experimental treatments for hepatitis C in a market worth billions of dollars. The drugs being developed by the two companies work by blocking different proteins than those attacked by traditional treatments for the serious liver …

Mozambican activists warned Friday that funding cuts by donors could cause a shortage of drugs for AIDS patients next year, undermining gains in curbing the disease's spread.

CAPE TOWN (Reuters) - South Africa wants to cut new HIV infection rates by at least 50 percent within five years as it seeks to build on recent successes following years of failing to tackle AIDS and increased mortality, President Jacob Zuma said on Thursday. Former President Thabo Mbeki was widely criticised for failing …

WEDNESDAY, Nov. 30 (HealthDay News) -- People taking the blood-thinning drug warfarin who monitor their own blood and adjust their dosage can reduce the risk of blood clots by half, British researchers report.

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

THURSDAY, Dec. 1 (HealthDay News) -- The first generic version of the cholesterol-lowering statin Lipitor (atorvastatin calcium) has been approved by the U.S. Food and Drug Administration.

WASHINGTON (Reuters) - Three leading senators are inquiring into drugmaker Pfizer Inc's efforts to limit the sale of generic versions of its Lipitor cholesterol drug, which lost U.S. patent protection this week. Their concern was prompted by a newspaper report earlier this month that Pfizer had struck deals with leading …

(Reuters) - A federal appeals court on Thursday refused to revive Teva Pharmaceutical Industries Ltd's patent infringement suit against AstraZeneca Pharmaceuticals LP for the rights to Crestor, a multibillion-dollar cholesterol fighter. In a ruling that upheld a lower court, the U.S. Court of Appeals for the Federal Circuit …

WASHINGTON (Reuters) - Three leading U.S. senators are inquiring into drugmaker Pfizer Inc's efforts to limit the sale of generic versions of its Lipitor cholesterol drug, which lost U.S. patent protection on Wednesday. Pfizer has made arrangements with some insurers and pharmacy benefit managers, which negotiate prices …

NEW YORK (Reuters Health) - Despite plenty of evidence that people with low levels of "good" cholesterol are more prone to heart attacks, a large new study suggests that the lacking lipid is not to blame. The analysis of data on nearly 70,000 people in Denmark affirmed the link between low levels of high-density lipoprotein …

President Barack Obama set an ambitious goal Thursday for significantly increasing access to life-saving AIDS drugs for people in the U.S. and around the world, as he announced a renewed American commitment to ending a pandemic that has killed 30 million people.

NEW YORK (Reuters Health) - After getting a urinary tract infection, kids in Finland had fewer recurring infections over the next year when they drank cranberry juice every day in a new study. Because the infections can damage the kidneys, along with being uncomfortable, both children and adults who get repeated UTIs may …

CAPE TOWN (Reuters) - South Africa wants to cut new HIV infection rates by at least 50 percent within five years as it seeks to build on recent successes following years of failing to tackle AIDS and increased mortality, President Jacob Zuma said on Thursday. Former President Thabo Mbeki was widely criticized for failing …

HONG KONG (Reuters) - Teenagers in Asia receiving treatment for HIV are showing early signs of osteoporosis and children as young as five are becoming resistant to AIDS drugs, an anti-AIDS group said on Thursday, urging more attention be given to young HIV patients. The finding, made available on World AIDS Day, is a reminder …

President Jacob Zuma on Thursday unveiled a plan to halve the number of HIV infections over the next five years, cementing South Africa's turnaround from years of deadly denialism.

Pfizer's patent on the best-selling drug of all-time, the cholesterol-lowering medication Lipitor, expired on Wednesday, opening the path to generic competitors for America's most popular medication.

As people with HIV live longer, South African life insurance providers are offering more policies to tap into a growing market, but for many people the premiums remain prohibitively expensive.

Health officials in the nation's largest city are recommending that any residents living with HIV be offered AIDS drugs as soon as the virus is diagnosed, an aggressive move that has been shown to prolong life and stem the spread of the disease.

In the United States, elderly patients with dementia are too often prescribed anti-psychotic drugs to calm their disruptive behavior, a costly and risky practice that should end, experts said Wednesday

President Barack Obama is renewing the U.S. commitment to ending AIDS Thursday, setting new goals for getting more people access to life-saving drugs and boosting spending on treatment in the U.S. by $50 million dollars.